- Home
- EVRG vs ITCI Comparison
EVRG vs ITCI Comparison
Compare EVRG & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRG
- ITCI
- Stock Information
- Founded
- EVRG 2017
- ITCI 2002
- Country
- EVRG United States
- ITCI United States
- Employees
- EVRG N/A
- ITCI N/A
- Industry
- EVRG Power Generation
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- EVRG Utilities
- ITCI Health Care
- Exchange
- EVRG Nasdaq
- ITCI Nasdaq
- Market Cap
- EVRG 13.9B
- ITCI 13.5B
- IPO Year
- EVRG N/A
- ITCI N/A
- Fundamental
- Price
- EVRG $63.16
- ITCI $126.20
- Analyst Decision
- EVRG Strong Buy
- ITCI Buy
- Analyst Count
- EVRG 7
- ITCI 13
- Target Price
- EVRG $65.07
- ITCI $100.31
- AVG Volume (30 Days)
- EVRG 1.8M
- ITCI 4.3M
- Earning Date
- EVRG 02-27-2025
- ITCI 02-20-2025
- Dividend Yield
- EVRG 4.23%
- ITCI N/A
- EPS Growth
- EVRG 25.01
- ITCI N/A
- EPS
- EVRG 3.70
- ITCI N/A
- Revenue
- EVRG $5,777,800,000.00
- ITCI $613,728,000.00
- Revenue This Year
- EVRG $6.50
- ITCI $48.41
- Revenue Next Year
- EVRG $2.86
- ITCI $38.26
- P/E Ratio
- EVRG $17.07
- ITCI N/A
- Revenue Growth
- EVRG 3.18
- ITCI 46.08
- 52 Week Low
- EVRG $48.04
- ITCI $62.78
- 52 Week High
- EVRG $65.47
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- EVRG 62.01
- ITCI 85.88
- Support Level
- EVRG $59.67
- ITCI $126.00
- Resistance Level
- EVRG $61.03
- ITCI $128.00
- Average True Range (ATR)
- EVRG 0.90
- ITCI 2.35
- MACD
- EVRG 0.27
- ITCI 4.86
- Stochastic Oscillator
- EVRG 95.10
- ITCI 96.18
About EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission Co. The utility has a combined rate base of approximately $20 billion, about half in Kansas and the rest split between Missouri and federal jurisdiction. Evergy is one of the largest wind energy suppliers in the US.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.